Advertisement

Topics

Companies Related to "Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers" [Most Relevant Company Matches] - Page: 2 RSS

13:20 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers" found in our extensive corporate database of over 50,000 company records.

Showing "Effects CRF1 Receptor Antagonist Human Startle Normal Female" Companies 26–50 of 2,600+

Relevant

ENBREL

ENBREL is a type of protein called a tumor necrosis factor (TNF) blocker that blocks the action of a substance your body's immune system makes called TNF. People with an immune disease, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, have too much TNF in their bodies. ENBREL can reduce the amount of TNF in the body to normal levels, helping to treat your d...


Agensys

Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets. The Company has discovered and validated a rich portfolio of novel, clinically relevant cancer targets to 14 different cancer types that have been carefully selected to enable development of new effective therapeutics with fewer and less ...

Receptor Biology Incorporated

Receptor Biology Inc. produce cloned receptors for pharmacology studies and drug discovery, products include adenosine, cannabinoid, dopamine, muscarinic, serotonin, opoid, bradykinin, transporter, wild type.


Receptor BioLogix

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of protein therapeutics called Intron Fusion Proteins™ (IFP™) to treat cancer, autoimmune, metabolic and other diseases.

Receptor BioLogix, Inc.

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of protein therapeutics called Intron Fusion Proteins™ (IFP™) to treat cancer, autoimmune, metabolic and other diseases.

PanVera Corporation

Protein Kinase C Assays Androgen Receptor, Ligand Binding Domain Estrogen Receptor-Beta 1, Long Form Tau Protein, microtubule-associated protein, histidine-tagged Cytochrome P450 Monoclonal Antibodiesa broad selection of antibodies can be found here.

Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals develops innovative therapeutics based on targets with established proofs of concept that are designed to provide significant advances over current treatments for cardiovascular disease and inflammation. The company has global development and commercialization agreements with two of the world's leading pharmaceutical companies collectively valued at about $1 billion in upfr...

BioCancell Therapeutics

BioCancell Therapeutics Inc. is a biopharmaceuticals corporation specializing in the development of Targeted Cancer Therapy for the treatment of numerous types of cancer. The Company's proprietary technology constitutes a novel paradigm for the targeted destruction of cancer cells, with no effect on normal surrounding tissue and no observed side effects, a...

LifeSensors Incorporated

Founded in July of 1996, LifeSensors Inc. is a privately held biotech company located 35 miles west of Philadelphia developing cell-based biosensors, known as LiveSensors™ for diagnostic and therapeutic markets.With the completion of the Human Genome Project, new technologies are required to understand the functions of human genes (functional genomics). LifeSensors Inc. will be the first company...

GTX

GTx, Inc., headquartered in Memphis, Tennessee, is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel hormonal therapeutics for cancer and serious conditions related to men’s health. GTx's lead drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens. GTx is developing...

DiscoveryBioMed, Inc.

DiscoveryBioMed, Inc. is a life sciences and biotechnology company that engages in R&D and services work in human cell engineering and production and human cell-based drug discovery. The company is located within The Innovation Depot facility in Birmingham, Alabama. Using physiologically relevant cell culture models preferably derived from normal and disea...

Cortex Pharmaceuticals

Cortex Pharmaceuticals Incorporated is a development stage enterprise that was organized in 1987 to engage in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurodegenerative diseases and other neurological and psychiatric disorders. Since 1993, the primary effort at Cortex has been centered on developing products that affect the AMPA-type gluta...

karo bio

KARO BIO IS AN ESTABLISHED GLOBAL LEADER IN THE FIELD OF NUCLEAR RECEPTOR RESEARCH AND DRUG DISCOVERY.Karo Bio is committed to finding new and better pharmaceuticals that can effectively treat serious diseases without the deleterious side effects commonly experienced with today's drugs.Karo Bio is a drug discovery company focusing its research on the discovery and pre-clinical phases of drug devel...

Athenagen, Inc

Athenagen, Inc., located in South San Francisco, is engaged in the development of small-molecule drugs that act on the nicotinic acetylcholine (nACh) receptor pathway. The company's lead nACh receptor agonists and antagonists are being developed to treat diseases associated with enhanced or impaired angiogenesis and in diseases where cognitive deficit plays a significant role. Athenagen currently ...

RxIBR for Health Arising™

The pivotal guiding scientific principle for Health Arising 2003 is that of Targeted Biologic Therapy™. Each of the RxIBR developed pharmaceutical biologicals (animal origin) and/or botanicals (plant origin) either activate receptors in the human body or directly activate cellular mechanisms of the human body thus providing a physiological/biochemical action. There are a myriad of specific rece...

Peoples Custom Rx.

In 1997 Peoples Custom Rx., primarily a compounding pharmacy, was established. We prepare sterile and non-sterile products, and provide infusion services. We prepare IV antibiotics, pain pumps, TPN, chemo therapy, capsules, suppositories, troches, creams, ointments, and eye drops. Natural hormone replacement, nutritional, diabetic and respiratory counseling are also important areas of our practice...

Longenity Inc

Longenity Inc. is a biotechnology company using genomics, bioinformatics, and systems biology, founded for the purpose of understanding normal aging, and common pathologies of human aging. Longenity has exhausted its funding and its working founders are returning to academic research. However, we are continuing to research aging and occasionally require the participation of human subjects. Dr. Es...

Cynvec LLC

Cynvec, a privately held biotechnology company, is developing proprietary cancer therapies based on the apoptotic sindbis oncolytic viral vector, a novel technology that targets the over expressed laminin receptor on the surface of many solid tumors without affecting normal cells. Under an exclusive worldwide license from the NYU School of Medicine, Cynvec is developing its lead product, CYN 101, ...

DanioLabs Ltd

DanioLabs (Cambridge UK) is a therapeutics company that has two primary business streams:Internal R&D investigating new uses for established drugs (Reprofiling) Phenotypic evaluation of compounds for other organisations, either for activity effects, or for preclinical safety pharmacology As part of our approach, we use zebrafish as a key enabling technology. zebrafish as an experimental species pr...

Ascent Scientific

Ascent Scientific offers a range of high quality receptor ligands and synthetic chemistry services at prices so low that as many researchers as possible will be able to afford them. The Low-Cost Ligand range includes receptor ligands and signalling tools in research areas such as glutamate, GABA, ion channels, cannabinoids, opioids, 5-HT and more. The Low-Cost Chemistry Service provid...

Psychiatric Genomics, Inc.

Dr. C. Anthony Altar is President and Chief Scientific Officer at Psychiatric Genomics. His research team is responsible for gene discovery, medicinal chemistry, and drug discovery efforts. Dr. Altar has published 120 articles in peer-reviewed journals that include Science, Nature, PNAS, and the Burger’s Medicinal Chemistry series. He pioneered methods for receptor localization using computerize...

Puracyp, Inc.

Puracyp began operations in 1993 focusing on the distribution of monospecific inhibitory antibodies to several human P450 enzymes. Members of the pharmaceutical industry used these antibodies to assess the contribution of a single P450 enzyme to a drug metabolizing reaction. Researchers also used anti-human P450 immunoglobulins in Western blotting experiments to determine expression of individual ...

Actelion Pharmaceuticals US, Inc.

Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion's first drug Tracleer® (bosentan), an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Actelion markets Tracleer® through its own subsidiaries in key markets worldwide, including the United States (based in ...

The Female Health Company

Pharmacopeia Drug Discovery

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting angiotensin and endothelin receptor antagonist (DARA) for hypertension and diabetic kidney disease for which Phase...


More From BioPortfolio on "Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks